Development of a Therapeutic Respiratory THC Dry Powder Inhaler

2018-04-20T13:39:23-05:00September 1st, 2015|Emerging Technology, Formulation Development, Medical, Pharamaceutical|

ARE Labs has been recently granted a Schedule 1 Research Drug License approved by DEA, NIH/NIDA & FDA for research into the feasibility of delivery of THC and THC-CBD via [...]